(Q40711748)

English

Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials

scientific article published on March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

phase III clinical trial

0 references

multicenter clinical trial

0 references

Streptococcus pneumoniae

1 reference

based on heuristic

1 reference

based on heuristic

author name string

Fogarty CM

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Greenberg RN

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Dunbar L

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Player R

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Marrie TJ

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kojak CM

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Morgan N

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Williams RR

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

425-439

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in infectious diseases mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. The Alexander Project

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transposable multiple antibiotic resistance in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980047-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80047-3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40711748&oldid=2098122603"